Loperamide potentiates doxorubicin sensitivity in triple‐negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl‐2: In vitro and molecular docking study
2020 ◽
Vol 3
(6)
◽
pp. 1330-1338
◽
2020 ◽
Vol 135
◽
pp. 110869
◽
2016 ◽
Vol 38
(3)
◽
pp. 1003-1014
◽
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 49
(6)
◽
pp. 2629-2636
◽
Keyword(s):
Keyword(s):
Keyword(s):